英集芯策划自问自答被立案调查，涉脑机接口芯片误导性陈述

Core Viewpoint - The China Securities Regulatory Commission (CSRC) has initiated an investigation into Shenzhen Injoinic Technology Co., Ltd. (Injoinic) for misleading statements regarding its IPA1299 chip on the Shanghai Stock Exchange's E-interaction platform [1][2]. Group 1: Company Actions and Responses - On January 6, 2026, Injoinic claimed on the E-interaction platform that it had entered the brain-computer interface chip sector with its IPA1299 chip, which was said to be capable of high-precision measurement of human bioelectrical signals and had already been mass-produced [1][3]. - Following regulatory scrutiny, Injoinic clarified on January 7 that the IPA1299 chip was developed in collaboration with its affiliate, and it was still in the market cultivation phase, with no significant impact on the company's financial performance yet [1][2]. Group 2: Regulatory Findings and Market Reaction - The Shanghai Stock Exchange indicated that Injoinic's responses did not accurately reflect the product's launch entity, sales scale, and the significant technical differences from international products, leading to insufficient risk disclosure [2]. - Despite the clarification, Injoinic's stock price rose over 9% on January 7, closing at 22.48 yuan per share, an increase of 4.51% [2].